NTBL Notable Labs Ltd: Margin dodolan resik

Notable Labs Ltd - logo grafis emiten NTBL

Monthly sales margin dynamics demonstrate the risks of narrow specialization within the therapy forecasting IT system, while the value of 0.00 aligns with the current metric. Notable Labs, Ltd. (NTBL) generates revenue through precision oncology services for drug selection. The ecosystem integrates live-cell analysis with AI to determine treatment efficacy, creating a patient survival navigator.

Margin resik Notable Labs Corp (NTBL): kanggo periode 21.02.2024 - 02.11.2024

Notable Labs Corp (NTBL) - rincian metrik lan laporan keuangan

- rega saham lan prakiraan rega para ahli:
Pambiji fundamental:notablelabs.com - NTBL
Produk dadi Notable Labs Inc.

Notable Labs, Ltd. (NTBL) is scaling its IT platform for predicting the efficacy of oncology drugs through the expansion of its B2B segment. The net profit margin trend reflects the portion of profit remaining after covering all operating and tax expenses. Comparing current values with the historical trend allows for the identification of structural shifts in business efficiency. This indicator measures the company's ability to convert revenue into net income, which is critical for assessing asset value during market capture.

Analisis pesaing

ONC: Margin dodolan resik|Margin resik Halozyme Inc. (HALO)|Margin resik RevMed|Rentabilitas dodolan resik AAPG (Ascentage Pharma Group)|Margin dodolan resik CGON|UroGen Pharma - Rentabilitas dodolan resik|Bicara Therapeutics - Rentabilitas dodolan miturut bathi resik|Margin dodolan resik Personalis Inc PSNL|Erasca Oncology - Margin dodolan resik|Tingkat bathi resik DCTH (Delcath Corp)|YMAB: Margin dodolan resik|AURA - Margin dodolan perusahaan|CADL (Candel Therapeutics Inc.) - Margin dodolan resik|Rentabilitas dodolan resik ARAY (Accuray)|Rentabilitas dodolan miturut bathi resik SLS (SELLAS Life Sciences Group, Inc.)|ACTU - Margin resik|Margin resik Citius Oncology, Inc. CTOR|HURA - Rentabilitas dodolan miturut bathi resik|protaratx.com - Margin dodolan resik|FATE - Margin dodolan resik|WHWK: Margin dodolan resik|TScan Therapeutics (TCRX) - Margin dodolan resik|Margin resik Champions Oncology|Margin resik XBIT|Margin dodolan resik CVM|Rentabilitas dodolan miturut bathi resik OS Therapies Inc. OSTX|Margin resik Radiopharm Theranostics Limited RADX|artivabio.com (ARTV) - Margin resik|ANL - Margin resik|Margin resik verupharma.com|TPST: Margin dodolan resik|XLO - Margin dodolan perusahaan|Margin resik Renovaro|Margin dodolan resik muraloncology.com|Margin dodolan resik KAPA|Margin dodolan perusahaan OnKure Therapeutics, Inc.|Margin dodolan resik GDTC (w2.cytomed.sg)|CRIS - Rentabilitas dodolan miturut bathi resik|Apollomics - Margin dodolan resik|Tharimmune Corp (THAR) - Rentabilitas dodolan miturut bathi resik|ADVB: Margin dodolan resik|Rentabilitas dodolan miturut bathi resik Genprex|CLDI (Calidi Biotherapeutics, Inc.) - Margin dodolan resik|Rentabilitas dodolan resik SBFM (Sunshine Biopharma)|Margin resik Xenetic Bio (XBIO)|Margin resik SLRX (Salarius Pharma)|Kitov Pharma - Rentabilitas dodolan miturut bathi resik|American Oncology Network (AONC) - Margin resik|BeiGene - Margin dodolan resik|Checkpoint Therapeutics, Inc. (CKPT) - Rentabilitas dodolan miturut bathi resik|ELEV (Elevation Oncology, Inc.) - Rentabilitas dodolan miturut bathi resik|iCAD Inc. - Tingkat bathi resik|Rentabilitas dodolan miturut bathi resik IKNA|VIRX: Tingkat bathi resik|Margin resik MorphoSys Corporation (MOR)|NAYA - Margin resik|Margin dodolan resik AAPGV (Ascentage)